RBR-9jwgkv
Recruiting
未知
Efficacy and safety of Percutaneous Collagen Induction by Needles in the treatment of Frontal Fibrosing Alopecia
Hospital Universitário Walter Cantídeo Universidade Federal do Ceará0 sitesSeptember 28, 2020
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Hospital Universitário Walter Cantídeo Universidade Federal do Ceará
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients with clinical diagnosis of Frontal fibrosing alopecia will be selected, including those with increased frontotemporal recess, associated or not with follicular papules and rarefaction of eyebrows; or histopathological diagnosis compatible with frontal fibrosing alopecia with follow up appointments at the Dermatology Department of Walter Cantideo University Hospital. Patients must be aged between 18 and 70 years old and must sign who the Informed Consent Form (ICF), with availability to attend periodic appointment evaluations.
Exclusion Criteria
- •Patients with the following conditions will be excluded: Pregnancy; Vitiligo, psoriasis or other skin diseases that present Koebner's phenomenon (development of chronic dermatosis in trauma areas); Active infections in the areas to be treated with microneedling; Presence of keloids in previous scars; History of allergy to topical or injectable anesthetic; Patients with psychiatric disorders or other clinical diseases that contraindicate the procedure; Patients who refuse to sign the Informed Consent Form (ICF) or who are unable to attend to periodic appointment evaluations.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
The influence of percutaneous collagen induction with medical needling on patients with burn scars - a prospective interventional studyT20-T25T29-T32Burns and corrosions of external body surface, specified by siteBurns and corrosions of multiple and unspecified body regionsDRKS00012394BG Klinikum Duisburg gGmbHKlinik für Hand- & Plastische Chirurgie, Brandverletzungen10
Recruiting
Not Applicable
Collagenase treatment for ocular burnsCTRI/2021/08/035994Hyderabad Eye Research Foundation
Active, not recruiting
Phase 1
Efficacy and Safety of Continuous Subcutaneous Insulin Infusion of Faster-acting Insulin Aspart compared to NovoRapid® in Adults with Type 1 DiabetesEUCTR2010-024054-11-BEovo Nordisk A/S506
Completed
Phase 3
Efficacy and Safety of Continuous Subcutaneous Insulin Infusion of Faster-acting Insulin Aspart compared to NovoRapid® in Adults with Type 1 Diabetes.Diabetes type 110018424NL-OMON43891ovo Nordisk35
Active, not recruiting
Phase 1
Efficacy and Safety of Continuous Subcutaneous Insulin Infusion of Faster-acting Insulin Aspart compared to NovoRapid® in Adults with Type 1 DiabetesEUCTR2010-024054-11-FRovo Nordisk A/S472